07 June 2019 | News
Taiwan to become a major biotech hub in Asia by its partnership with Taiwan Bio Industry organizations, promoting precision medicine, gene therapy, and digital health
Image Courtesy: Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO)
The world's largest annual event for the biomedical sector, BIO International Convention (BIO 2019), was held in Philadelphia, Pennsylvania from 3rd June to 6th June 2019. Taiwan Pavilions was one of the 3 major largest Pavilions at BIO 2019, where the Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO) under the Ministry of Economic Affairs of Taiwan hosted an opening ceremony on June 4, 2019. The opportunity was opened to explore Taiwan's technologies, products, regulations, and the environment in the biomedical field as well as Taiwan's capabilities for international collaborations.
The leader of Taiwan delegation to BIO 2019, also the Minister without Portfolio from Taiwan's Executive Yuan, Tsung-Tsong Wu, and the Ambassador, Lily L. W. Hsu, from the Taipei Economic and Cultural Office (TECO) in New York, were present at the event.
The President and CEO of the BIO, Jim Greenwood, announced the partnership with the Taiwan Bio Industry Organization and said: "For the first time we will be combining forces to present Bio Asia in Taiwan". The two organizations will collaborate to organize Bio Asia – Taiwan International Conference and Exhibition in Taipei from July 24 to 28, 2019. Over 18 countries and 1,700 exhibitors will be attending BIO Asia – Taiwan, making it be Asia's largest event for the biomedical sector.
Being listed as the top 10 largest international delegations, more than 210 delegates from Taiwan attended BIO 2019. A wide variety of events in Philadelphia were organized to increase networking opportunities and promote international collaborations between Taiwan and the world's biomedical sector. The Development Center for Biotechnology (DCB) and Temple University organized a Taiwan forum focused on global biotech entrepreneurship on June 2. The event was supported by Taiwanese American Association of Pharmaceutical Sciences (TAAP), and Investment and Trade Office, TECO in New York, and attracted 300 guests from Taiwan, USA and Italy. On June 3, three Taiwanese companies, Medical Vision, Riche Biotech, and Cell Envision attended the Innovation Challenge at the Redefining Early Stage Investments (RESI) to find fundraising opportunities. They were listed as the top 20 finalists out of 200 applicants from the world at the RESI Conference.
Ambassador Wu said exhibitors at Taiwan Pavilion focused on promoting some very emerging technologies, such as precision medicine, gene therapy, and digital health at BIO 2019. Over 39 Taiwanese companies were exhibiting, presenting 61 technologies and products, as well as participating at one-on-one partnering meetings at the convention.